Biopharmaceutical News and Research

RSS
Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Emerging nanomedicine technologies could dramatically transform medical science

Emerging nanomedicine technologies could dramatically transform medical science

Neuro3d identifies candidate compound

Neuro3d identifies candidate compound

Outsourcing the way to control spiraling R&D budgets in drug industry

Outsourcing the way to control spiraling R&D budgets in drug industry

Autodesk engineering solution addresses healthcare design challenges

Autodesk engineering solution addresses healthcare design challenges

Research tests the efficacy of a smallpox vaccine candidate known as LC16m8

Research tests the efficacy of a smallpox vaccine candidate known as LC16m8

Genetically engineered viruses may create new class of cancer therapies

Genetically engineered viruses may create new class of cancer therapies

Biochip technology to revolutionise the pharmaceutical industry

Biochip technology to revolutionise the pharmaceutical industry

IBM introduces new BioPharmaceutical solution

IBM introduces new BioPharmaceutical solution

Ingenium's acquisition of US patents may lead to drug discovery and development

Ingenium's acquisition of US patents may lead to drug discovery and development

FDA approves INFUSE® bone graft which improves fracture healing

FDA approves INFUSE® bone graft which improves fracture healing

Wyeth gets FDA approval for a novel protein device that enhances bone healing

Wyeth gets FDA approval for a novel protein device that enhances bone healing

Carbohydrate-binding proteins are becoming extremely useful in curing various illnesses

Carbohydrate-binding proteins are becoming extremely useful in curing various illnesses

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

Coronary stent drives Johnson & Johnson to record profits

Coronary stent drives Johnson & Johnson to record profits

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

Oxford Biomedica to win Department of Health gene funding

Oxford Biomedica to win Department of Health gene funding

Immunomodulator induces long-term anti-tumor activity

Immunomodulator induces long-term anti-tumor activity

New treatment for heart attacks

New treatment for heart attacks

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.